Author:
Gupta Dhruv Sanjay,Gadi Vaishnavi,Kaur Ginpreet,Gupta Madhu,Kumar Ajay,Tuli Hardeep Singh
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,Genetics,Biochemistry
Reference77 articles.
1. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO. Parity, age at first childbirth, and risk of ovarian cancer. Lancet (London, England). 1994;344(8932):1250–4. https://doi.org/10.1016/s0140-6736(94)90749-8.
2. Asgharian P, Tazehkand AP, Soofiyani SR, Hosseini K, Martorell M, Tarhriz V, Ahangari H, et al. ‘Quercetin impact in pancreatic cancer: an overview on its therapeutic effects’. Edited by Felipe L. de Oliveira. Oxidative Med Cell Longev. 2021;2021(November):1–13. https://doi.org/10.1155/2021/4393266.
3. Ashraf AH, Zuberi M, Afroze SH, Yamauchi K, Zawieja DC, Keuhl TJ, Erlandson LW, Uddin MN. Differential mechanism of action of 3,4′,7-O-trimethylquercetin in three types of ovarian cancer cells. Anticancer Res. 2018;38(9):5131–7. https://doi.org/10.21873/anticanres.12835.
4. Askari G, Ghiasvand R, Feizi A, Ghanadian SM, Karimian J. The effect of quercetin supplementation on selected markers of inflammation and oxidative stress. J Res Med Sci. 2012;17(7):637–41.
5. Bonifácio VDB. Ovarian cancer biomarkers: moving forward in early detection. Adv Exp Med Biol. 2020;1219:355–63. https://doi.org/10.1007/978-3-030-34025-4_18.